| Application | Recommended Dilution |
|---|---|
| FC | 1:50-1:200 |
CD80, also known as B7-1, serves as a critical costimulatory molecule on the surface of antigen-presenting cells, where it engages CD28 and CTLA-4 receptors on T lymphocytes to regulate immune activation and tolerance. This interaction represents a fundamental checkpoint in adaptive immunity, making CD80 a compelling target for researchers investigating T cell biology, autoimmune mechanisms, and immunotherapy development.
This recombinant monoclonal antibody against human CD80, clone 19G10, offers the reproducibility and consistency that demanding immunological studies require. Because it is produced through recombinant technology with a defined sequence, researchers can expect uniform performance across experiments and between lots, eliminating the variability that can complicate longitudinal studies or multi-site collaborations. The human IgG1 isotype format provides predictable binding characteristics for flow cytometry applications.
Validation studies demonstrate clear detection of CD80 on Raji cells, a well-established B lymphoblast line that constitutively expresses this costimulatory molecule. Flow cytometry analysis at 1:100 dilution showed distinct positive staining compared to isotype control, with recommended working dilutions ranging from 1:50 to 1:200 depending on experimental conditions. The antibody has also been validated for ELISA applications, providing flexibility for researchers who need to assess CD80 levels across different experimental platforms.
Supplied in a stabilized liquid format containing glycerol and PBS with Proclin 300 preservative, this affinity-purified antibody is ready for immediate use in your immunology research. Whether you are characterizing antigen-presenting cell populations, investigating costimulatory pathways, or developing immune checkpoint assays, this antibody delivers the specificity and consistency your experiments demand.
Email: support@cusabio.com
Distributors Worldwide